{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T21:22:10Z","timestamp":1773696130395,"version":"3.50.1"},"reference-count":72,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.drudis.2009.01.004","type":"journal-article","created":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T04:19:57Z","timestamp":1233461997000},"page":"428-435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Insights into liaison between antiepileptic drugs and bone"],"prefix":"10.1016","volume":"14","author":[{"given":"Suruchi","family":"Khanna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishna K.","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya","family":"Vohora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2009.01.004_bib1","first-page":"378","article-title":"Osteopathies in antiepileptic long-term therapy (preliminary report)","volume":"116","author":"Kruse","year":"1968","journal-title":"Monatsschr. Kinderheilkd."},{"key":"10.1016\/j.drudis.2009.01.004_bib2","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/bmj.4.5894.695","article-title":"Incidence of anticonvulsant osteomalacia and effect of vitamin D: controlled therapeutic trial","volume":"4","author":"Christiansen","year":"1973","journal-title":"Br. Med. J."},{"key":"10.1016\/j.drudis.2009.01.004_bib3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1053\/seiz.1999.0301","article-title":"Bone density and antiepileptic drugs: a case-controlled study","volume":"8","author":"Stephen","year":"1999","journal-title":"Seizure"},{"key":"10.1016\/j.drudis.2009.01.004_bib4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1212\/WNL.57.3.445","article-title":"Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy","volume":"57","author":"Sato","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.drudis.2009.01.004_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2217\/14750708.4.1.79","article-title":"Expanding use of anti-epileptic therapy: implications on bone disease","volume":"4","author":"Arora","year":"2007","journal-title":"Therapy"},{"key":"10.1016\/j.drudis.2009.01.004_bib6","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1212\/01.wnl.0000180910.72487.18","article-title":"Effect of antiepileptic medication on bone mineral measures","volume":"65","author":"Petty","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.drudis.2009.01.004_bib7","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.1212\/01.WNL.0000129704.29460.FA","article-title":"Antiseizure drugs and reduced bone density","volume":"62","author":"Gross","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.drudis.2009.01.004_bib8","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0387-7604(94)90125-2","article-title":"Effects of anti-epileptic drug therapy on bone mineral density in ambulatory epileptic children","volume":"16","author":"Chung","year":"1994","journal-title":"Brain Dev."},{"key":"10.1016\/j.drudis.2009.01.004_bib9","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1212\/WNL.39.6.858","article-title":"Seizure as a cause of fracture","volume":"39","author":"Finelli","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.drudis.2009.01.004_bib10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.yebeh.2003.11.030","article-title":"Fractures, epilepsy, and antiepileptic drugs","volume":"5","author":"Mattson","year":"2004","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.drudis.2009.01.004_bib11","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1474-4422(04)00848-8","article-title":"Bone health in epilepsy","volume":"3","author":"Sheth","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.drudis.2009.01.004_bib12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1600-0404.1999.tb00675.x","article-title":"Fracture risk is increased in epilepsy","volume":"99","author":"Vestergaard","year":"1999","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.drudis.2009.01.004_bib13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1148\/radiol.2481070986","article-title":"Osteoporotic fracture risk in elderly women: estimation with quantitative heel US and clinical risk factors","volume":"248","author":"Guessous","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.drudis.2009.01.004_bib14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1600-0404.2005.00474.x","article-title":"Epilepsy, osteoporosis and fracture \u2013 a meta-analysis","volume":"112","author":"Vestergaard","year":"2005","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.drudis.2009.01.004_bib15","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1212\/WNL.58.9.1348","article-title":"Effect of antiepileptic drugs on bone density in ambulatory patients","volume":"58","author":"Farhat","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.drudis.2009.01.004_bib16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1528-1157.2002.13001.x","article-title":"The importance of drug interactions in epilepsy therapy","volume":"43","author":"Patsalos","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.drudis.2009.01.004_bib17","first-page":"113","article-title":"A prospective study to evaluate the dose of vitamin D required to correct 25-hydroxyvitamin D levels, calcium and alkaline phosphatase in patients at risk of developing antiepileptic drug-induced osteomalacia","volume":"286","author":"Collins","year":"1991","journal-title":"Q. J. Med."},{"key":"10.1016\/j.drudis.2009.01.004_bib18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1172\/JCI21867","article-title":"Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia","volume":"115","author":"Pascussi","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drudis.2009.01.004_bib19","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1210\/endo.141.7.7579","article-title":"Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D","volume":"141","author":"St-Arnaud","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.drudis.2009.01.004_bib20","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1172\/JCI24742","article-title":"c-Fos protein as a target of anti-osteoclastogenic action of vitamin D, and synthesis of new analogs","volume":"116","author":"Hisashi","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drudis.2009.01.004_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1172\/JCI200523995","article-title":"Stay tuned to PXR: an orphan actor that may not be D-structive only to bone","volume":"115","author":"Michael","year":"2005","journal-title":"Clin. Invest."},{"key":"10.1016\/j.drudis.2009.01.004_bib22","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/jn\/131.6.1787","article-title":"Vitamin D receptor null mutant mice fed high levels of calcium are fertile","volume":"131","author":"Johnson","year":"2001","journal-title":"J. Nutr."},{"key":"10.1016\/j.drudis.2009.01.004_bib23","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.bone.2004.02.003","article-title":"The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis","volume":"35","author":"Sahota","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.drudis.2009.01.004_bib24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.mce.2005.09.008","article-title":"Current insights into the role of transforming growth factor-\u03b2 in bone resorption","volume":"243","author":"Foxa","year":"2005","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.drudis.2009.01.004_bib25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1385\/BMM:2:2:159","article-title":"Antiepileptic drugs and bone disease","volume":"2","author":"Pack","year":"2004","journal-title":"Clin. Rev. Bone Miner. Metab."},{"key":"10.1016\/j.drudis.2009.01.004_bib26","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.mehy.2007.08.024","article-title":"Calcitonin may be a useful therapeutic agent for osteoclastogenesis syndromes involving premature eruption of the tooth","volume":"70","author":"Qin","year":"2008","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.drudis.2009.01.004_bib27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1535-7597.2003.03306.x","article-title":"The association between antiepileptic drugs and bone disease","volume":"3","author":"Pack","year":"2003","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.drudis.2009.01.004_bib28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/jbmr.5650030215","article-title":"Inhibition by phenytoin of in vitro secretion of calcitonin from rat thyroid glands and cultured rat C cells","volume":"3","author":"Cooper","year":"1988","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.drudis.2009.01.004_bib29","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1001\/jama.1996.03530430039036","article-title":"Normal serum free thyroid hormone concentrations in patients treated with phenytoin or carbamazepine. A paradox resolved","volume":"275","author":"Surks","year":"1996","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.drudis.2009.01.004_bib30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.berh.2007.11.006","article-title":"Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations","volume":"22","author":"Egbuna","year":"2008","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.drudis.2009.01.004_bib31","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(95)90227-9","article-title":"Vitamin K","volume":"345","author":"Shearer","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2009.01.004_bib32","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1172\/JCI116387","article-title":"Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women","volume":"91","author":"Szulc","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drudis.2009.01.004_bib33","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/ajcn\/71.5.1201","article-title":"Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women","volume":"71","author":"Booth","year":"2000","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.drudis.2009.01.004_bib34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S8756-3282(98)00092-1","article-title":"Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin","volume":"23","author":"Boskey","year":"1998","journal-title":"Bone"},{"key":"10.1016\/j.drudis.2009.01.004_bib35","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/0115426507022005517","article-title":"Bone health and osteoporosis: the role of vitamin K and potential antagonism by anticoagulants","volume":"22","author":"Pearson","year":"2007","journal-title":"Nutr. Clin. Pract."},{"key":"10.1016\/j.drudis.2009.01.004_bib36","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0899-9007(02)00962-0","article-title":"Effects of menatetrenone on the bone and serum levels of vitamin K2 (menaquinone derivatives) in osteopenia induced by phenytoin in growing rats","volume":"19","author":"Onodera","year":"2003","journal-title":"Nutrition"},{"key":"10.1016\/j.drudis.2009.01.004_bib37","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/382448a0","article-title":"Increased bone formation in osteocalcin-deficient mice","volume":"382","author":"Ducy","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2009.01.004_bib38","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/clpt.1983.209","article-title":"Vitamin K-dependent proteins and anticonvulsant medication","volume":"34","author":"Keith","year":"1983","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drudis.2009.01.004_bib39","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1359\/jbmr.2002.17.3.394","article-title":"Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis","volume":"17","author":"Dang","year":"2002","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.drudis.2009.01.004_bib40","doi-asserted-by":"crossref","first-page":"7829","DOI":"10.1073\/pnas.130200197","article-title":"Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression","volume":"97","author":"Shevde","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2009.01.004_bib41","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cell.2007.07.025","article-title":"Estrogen prevents bone loss via estrogen receptor alpha and induction of fas ligand in osteoclasts","volume":"130","author":"Nakamura","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2009.01.004_bib42","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1002\/art.23500","article-title":"Aromatase expression in osteoarthritic and osteoporotic bone","volume":"58","author":"Hernandez","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.drudis.2009.01.004_bib43","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1507\/endocrj.46.301","article-title":"Estrogen supplementation for bone dematuration in young epileptic man treated with anticonvulsant therapy; a case report","volume":"46","author":"Yamano","year":"1999","journal-title":"Endocr. J."},{"key":"10.1016\/j.drudis.2009.01.004_bib44","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0890-6238(02)00020-5","article-title":"Valproate irreversibly alters steroid secretion patterns from porcine follicular cells in vitro","volume":"16","author":"Tauboll","year":"2002","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.drudis.2009.01.004_bib45","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tiv.2007.09.004","article-title":"Inhibition of human aromatase complex (CYP19) by antiepileptic drugs","volume":"22","author":"Jacobsen","year":"2008","journal-title":"Toxicol. In vitro"},{"key":"10.1016\/j.drudis.2009.01.004_bib46","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2165\/00023210-200519030-00003","article-title":"Effect of antiepileptic drugs on reproductive endocrine function in individuals with epilepsy","volume":"19","author":"Isojarvi","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.drudis.2009.01.004_bib47","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1172\/JCI28550","article-title":"Estrogen deficiency and bone loss: an inflammatory tale","volume":"116","author":"Weitzmann","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drudis.2009.01.004_bib48","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1468-1331.2004.00899.x","article-title":"Antiepileptic drugs alter reproductive endocrine hormones in men with epilepsy","volume":"12","author":"R\u00f8ste","year":"2005","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.drudis.2009.01.004_bib49","first-page":"M405","article-title":"Valproic acid inhibits osteoblast and osteoclast activity in therapeutic dose ranges","author":"Gracious","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.drudis.2009.01.004_bib50","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1111\/j.1528-1167.2007.01176.x","article-title":"Levetiracetam, phenytoin, and valproate act differently on rat bone mass, structure and metabolism","volume":"48","author":"Nissen-Meyer","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.drudis.2009.01.004_bib51","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1254\/jjp.82.82","article-title":"Phenytoin and its metabolite, 5-(4-hydroxyphenyl)-5-phenylhydantoin, show bone resorption in cultured neonatal mouse calvaria","volume":"82","author":"Takahashi","year":"2000","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.drudis.2009.01.004_bib52","first-page":"37","article-title":"Long-term anticonvulsant therapy leads to low bone mineral density-evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast-like cells","volume":"108","author":"Feldkamp","year":"2000","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.drudis.2009.01.004_bib53","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0920-1211(01)00288-1","article-title":"Antiepileptic drugs as independent predictors of plasma total homocysteine levels","volume":"47","author":"Apeland","year":"2001","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.drudis.2009.01.004_bib54","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0024-3205(87)90562-5","article-title":"Valproic acid-induced neural tube defects: reduction by folinic acid in the mouse","volume":"41","author":"Trotz","year":"1987","journal-title":"Life Sci."},{"key":"10.1016\/j.drudis.2009.01.004_bib55","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1056\/NEJMoa032739","article-title":"Homocysteine as a predictive factor for hip fracture in older persons","volume":"350","author":"McLean","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drudis.2009.01.004_bib56","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0925-4439(95)00119-0","article-title":"Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria","volume":"1315","author":"Lubec","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drudis.2009.01.004_bib57","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1359\/jbmr.060406","article-title":"Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation","volume":"21","author":"Koh","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.drudis.2009.01.004_bib58","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1528-1157.1972.tb05167.x","article-title":"Influence of diphenylhydantoin and phenobarbital on intestinal calcium transport in the rat","volume":"13","author":"Koch","year":"1972","journal-title":"Epilepsia"},{"key":"10.1016\/j.drudis.2009.01.004_bib59","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0006-2952(76)90161-1","article-title":"Diphenylhydantoin: direct inhibition of the vitamin D3-mediated calcium absorptive mechanism in organ cultured duodenum","volume":"25","author":"Corradino","year":"1976","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.drudis.2009.01.004_bib60","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ics.2005.06.102","article-title":"Effects of antiepileptics phenytoin, zonisamide and valproate on bone metabolism in growing rats","volume":"1284","author":"Takahashi","year":"2005","journal-title":"Inter. Congress Ser."},{"key":"10.1016\/j.drudis.2009.01.004_bib61","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1210\/endo-106-2-606","article-title":"Effects of diphenylhydantoin on synthesis of collagen and noncollagen protein in tissue culture","volume":"106","author":"Dietrich","year":"1980","journal-title":"Endocrinology"},{"key":"10.1016\/j.drudis.2009.01.004_bib62","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0960-894X(03)00029-5","article-title":"Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates\/sulfamides with isozymes I, II and IV","volume":"13","author":"Casini","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.drudis.2009.01.004_bib63","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.bmcl.2005.03.032","article-title":"Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies","volume":"15","author":"DeSimone","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.drudis.2009.01.004_bib64","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.0013-9580.2003.06203.x","article-title":"Dose-dependent induction of cytochrome P450 (CYP) 3A4 and activation of pregnane X receptor by topiramate","volume":"44","author":"Nallani","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.drudis.2009.01.004_bib65","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.yebeh.2007.01.003","article-title":"Oxcarbazepine improves mood in patients with epilepsy","volume":"10","author":"Mazza","year":"2007","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.drudis.2009.01.004_bib66","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1528-1167.2006.00460.x","article-title":"Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine","volume":"47","author":"Mintzer","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.drudis.2009.01.004_bib67","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0090-9556(24)15285-3","article-title":"In vitro evaluation of potential drug interactions with levetiracetam, a new antiepileptic agent","volume":"27","author":"Nicolas","year":"1998","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.drudis.2009.01.004_bib68","series-title":"Antiepileptic Drugs","author":"Levy","year":"2002"},{"key":"10.1016\/j.drudis.2009.01.004_bib69","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0920-1211(92)90011-H","article-title":"An assessment of serum and red blood cell folate concentrations in patients with epilepsy on lamotrigine therapy","volume":"13","author":"Sander","year":"1992","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.drudis.2009.01.004_bib70","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.yebeh.2006.11.007","article-title":"A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy","volume":"10","author":"Kim","year":"2007","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.drudis.2009.01.004_bib71","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.bone.2007.09.059","article-title":"Cost effectiveness of hormone therapy in women at high risks of fracture in Sweden, the US and the UK-Results based on the Women's Health Initiative randomised controlled trial","volume":"42","author":"Lekander","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.drudis.2009.01.004_bib72","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(07)60460-7","article-title":"The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644609000051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644609000051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:04:00Z","timestamp":1761221040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644609000051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":72,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S1359644609000051"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2009.01.004","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights into liaison between antiepileptic drugs and bone","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2009.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}